Aurobindo Pharma Limited
- All
- News
-
CSIR Collaborates With Aurobindo Pharma To Develop COVID-19 Vaccines
The Council of Scientific and Industrial Research (CSIR) and Aurobindo Pharma Limited on Tuesday announced a collaboration to develop vaccines for COVID-19.
-
Aurobindo Gets USFDA Nod for Esomol Hydrochloride Injection
It is indicated for the short-term treatment of tachycardia and hypertension that occur during induction and tracheal intubation, during surgery, on emergence from anaesthesia and in the postoperative period, it said.
-
Glenmark, Aurobindo Pharma Gain on Approval of Foreign Investment Proposals
Glenmark surged over 6 per cent to hit intraday high of Rs 898. The CCEA had yesterday cleared its proposal to increase foreign holding limit (FII limit) in the company to 49 per cent from 35.07 per cent now.
-
Aurobindo Pharma to Raise $350 Million Through QIP
The board had earlier constituted a securities issue committee comprising of five board members, including two independent directors, for issue of securities.
-
Aurobindo Pharma May Spend Rs 1,300 Crore Towards Capex in FY15-16
The capex will be spread out across APIs (active pharmaceutical ingredients) and formulations and the company's operations have resulted in substantial improvement to support the capex through internal cash generation, he said.
-
Aurobindo Pharma to acquire Activis' operations in 7 European nations
Generic drug maker Aurobindo Pharma has signed a binding offer agreement to acquire commercial operations of Dublin-based Actavis Plc in seven Western European countries.
-
Aurobindo Pharma Limited - Press Release
Aurobindo Pharma Limited has informed the Exchange regarding a Press Release dated June 03, 2010 titled "Aurobindo Pharma receives USFDA approvals for Ceftazidime for Injection"
-
Aurobindo Pharma Limited - Allotment of Securities
Aurobindo Pharma Ltd has informed the Exchange that regarding allotment of shares on Conversion of FCCBs.
-
Aurobindo Pharma Limited - Press Release
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated May 13, 2010, titled "Aurobindo Pharma recieves tentative approval for Rosuvastatin Calcium Tablets".
-
CSIR Collaborates With Aurobindo Pharma To Develop COVID-19 Vaccines
The Council of Scientific and Industrial Research (CSIR) and Aurobindo Pharma Limited on Tuesday announced a collaboration to develop vaccines for COVID-19.
-
Aurobindo Gets USFDA Nod for Esomol Hydrochloride Injection
It is indicated for the short-term treatment of tachycardia and hypertension that occur during induction and tracheal intubation, during surgery, on emergence from anaesthesia and in the postoperative period, it said.
-
Glenmark, Aurobindo Pharma Gain on Approval of Foreign Investment Proposals
Glenmark surged over 6 per cent to hit intraday high of Rs 898. The CCEA had yesterday cleared its proposal to increase foreign holding limit (FII limit) in the company to 49 per cent from 35.07 per cent now.
-
Aurobindo Pharma to Raise $350 Million Through QIP
The board had earlier constituted a securities issue committee comprising of five board members, including two independent directors, for issue of securities.
-
Aurobindo Pharma May Spend Rs 1,300 Crore Towards Capex in FY15-16
The capex will be spread out across APIs (active pharmaceutical ingredients) and formulations and the company's operations have resulted in substantial improvement to support the capex through internal cash generation, he said.
-
Aurobindo Pharma to acquire Activis' operations in 7 European nations
Generic drug maker Aurobindo Pharma has signed a binding offer agreement to acquire commercial operations of Dublin-based Actavis Plc in seven Western European countries.
-
Aurobindo Pharma Limited - Press Release
Aurobindo Pharma Limited has informed the Exchange regarding a Press Release dated June 03, 2010 titled "Aurobindo Pharma receives USFDA approvals for Ceftazidime for Injection"
-
Aurobindo Pharma Limited - Allotment of Securities
Aurobindo Pharma Ltd has informed the Exchange that regarding allotment of shares on Conversion of FCCBs.
-
Aurobindo Pharma Limited - Press Release
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated May 13, 2010, titled "Aurobindo Pharma recieves tentative approval for Rosuvastatin Calcium Tablets".
